Clinical Trial Update: ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients

View source ↗

Summary

ENDO-BRAIN is a clinical trial assessing the cognitive effects of aromatase inhibitor therapy in breast cancer patients; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitors (class)

Snippet

Sponsor: Ospedale Policlinico San Martino | Conditions: Cognitive Side Effects of Cancer Therapy, Hypoestrogenism | Status: RECRUITING